MedTrace Logo

A Investigator Masked Parallel Comparison of Tolerability of Combigan and Cosopt

NCT00621335 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64

Last updated 2013-02-25

No results posted yet for this study

Summary

The objective of this research study is to compare the tolerability and effectiveness of Combigan(brimonidine tartrate/timolol maleate) and Cosopt (dorzolamide hydrochloride)in the treatment of open angle glaucoma or ocular hypertension.

Conditions

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • DBYAN Medicine Professional Corporation

    lead OTHER

Principal Investigators

  • David Yan, M.D. · University of Toronto

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2008-02-29
Completion
2008-02-29

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00621335 on ClinicalTrials.gov